BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

Bse Healthcare

1D
1M
3M
6M
1Y
5Y
empty graph

Bse Healthcare Performance

Day's Range

Low

₹46,813.24

High

₹47,364.54

52 Week Range

Low

₹40,239.45

High

₹48,086.59

Previous Close ₹47,043.88
Day's Range ₹46,813.24 - ₹47,364.54
Open ₹47,306.98
52 Week Range ₹40,239.45 - ₹48,086.59
Volume 50,93,014

Bse Healthcare Companies

Company Name LTP (₹) Change (₹) Sector
Cipla Ltd. 1372.75 Arrow -8.75 (-0.63%) Healthcare
Dr. Reddy's Laboratories Ltd. 1277.85 Arrow -1.40 (-0.11%) Healthcare
Procter & Gamble Health Ltd. 6215.00 Arrow -21.80 (-0.35%) Healthcare
Lupin Ltd. 2270.10 Arrow -3.40 (-0.15%) Healthcare
Morepen Laboratories Ltd. 52.27 Arrow -0.10 (-0.19%) Healthcare
Torrent Pharmaceuticals Ltd. 4464.50 Arrow -44.45 (-0.99%) Healthcare
Abbott India Ltd. 26070.00 Arrow -198.00 (-0.75%) Healthcare
Glaxosmithkline Pharmaceuticals Ltd. 2194.00 Arrow 69.35 (3.26%) Healthcare
Novartis India Ltd. 1321.40 Arrow 26.30 (2.03%) Trading
Sanofi India Ltd. 3325.00 Arrow 76.95 (2.37%) Healthcare

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 23989.15 26373.20 22182.55
Nifty IT 28568.1 40301.40 27078.00
Nifty Next 50 71798.65 73098.95 59896.10
NIFTY50 USD Index 8791.7 10443.40 8132.40
Nifty Bank 57297.15 61764.85 49954.85
NIFTY Midcap 100 61802.05 62907.50 52032.85
Nifty 500 22997.25 24144.20 20385.65
Nifty Midcap 50 17607.15 17859.10 14804.55
Nifty 100 25029.9 26975.15 22720.45
Nifty FMCG 49642.4 58485.05 45334.15

Latest News

Jun
16
2026
EQUITY Posted on Jun 16th 2026

Akums Drugs and Pharmaceuticals informs about press release

Akums Drugs and Pharmaceuticals has informed that it enclosed copies of the newspaper advertisement published in Business Standard (English) and Business Standard (Hindi) on June 16, 2026, in compliance with General Circular No. 20/2020 dated May 05, 2020 issued by the Ministry of Corporate Affairs. Notice of the 22nd AGM and Integrated Annual Report for the F.Y. 2025-26 and other related information will be submitted in due course of time. A copy of this disclosure is being updated on website of the Company at www.akums.in
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
16
2026
EQUITY Posted on Jun 16th 2026

Krishna Institute of Medical Sciences informs about outcome of board meeting

Krishna Institute of Medical Sciences has informed that the Board of Directors at its meeting held on Friday, May 15 2026, considered and approved, the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2026. In furtherance to the aforesaid intimation, please find enclosed the audited Standalone and Consolidated Financial Statements of the Company for the year ended 31st March 2026, along with the audit reports issued thereon by the Statutory Auditors.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
16
2026
EQUITY Posted on Jun 16th 2026

Panacea Biotec informs about newspaper publication

Panacea Biotec has informed that it enclosed newspaper copies regarding notice intimating the investors about the opening of a Special Window for Transfer and Dematerialization of physical shares, in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, published on June 16, 2026, in the newspapers: Financial Express; and Desh Sewak (Punjabi).

The above information is a part of company’s filings submitted to BSE. 

Read More
Jun
16
2026
EQUITY Posted on Jun 16th 2026

Suven Life Sciences informs about press release

Suven Life Sciences has informed that it enclosed News Release of the company titled ‘Suven Life Sciences announces successful completion and topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107, a Muscarinic M1 Positive Allosteric Modulator (M1-PAM) and its advancement into Phase-2 clinical development’.
The above information is a part of company’s filings submitted to BSE. 
Read More
Jun
16
2026
EQUITY Posted on Jun 16th 2026

Neuland Laboratories informs about newspaper advertisement

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Neuland Laboratories has informed that it enclosed copies of newspaper advertisement regarding intimation of 42nd Annual General Meeting of the Company to be held through Video Conferencing (VC) facility/Other Audio Visual Means (OAVM), record date and other related information, as published in Financial Express and Nava Telangana on June 16, 2026.
The above information is a part of company’s filings submitted to BSE. 
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of index?

The previous close of index is ₹ as of .

The total volume of index is as of .

The percentage change in value of index is % as of .

The absolute increase in index value since the previous trading day is ₹ as of .

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore